 |
A Randomized, Double-Blind, Placebo-controlled Study Comparing the Analgesic Activity of ‘Drug A’ Extended Release and Placebo in Subjects with Pain Following Bunionectomy Surgery |
|
Clinical Protocol For A Multi-Center, Single Dose, Double-blind, Placebo-Controlled, Randomized, Pilot Study To Investigate the Assay Sensitivity of Single Digit Hammertoe Surgery As A Model For The Study Of Analgesic Drugs In Acute Pain. |
|
Revised Clinical Protocol for a Randomized Multiple Dose Assessment of the Safety of the ‘Drug A’ Ready to Use (RTU) Formulation Compared to Drug B Lyophilized Preparation in Patients in Pain Following Bunionectomy |
|
Clinical Protocol for a Randomized, Double-Blind, Placebo Controlled, Multiple Dose Assessment of the Analgesic Efficacy of the Dosing Regimen of ‘Drug A’ Compared to Placebo Patients in Pain Following Bunionectomy |
|
Clinical Protocol for a Multiple Dose Randomized, Double-Blind, Placebo Controlled Study of the Analgesic Efficacy and Safety of ‘Drug A’ Compared to Placebo in Patients for Treatment of Post-Surgical Pain from Bunionectomy Surgery |
|
A Randomized, Double-Blind, Parallel-Group Study Assessing the Analgesic Efficacy and Safety of Four Dose Levels of GRT0151Y (50 mg, 100 mg, 150 mg,and 200 mg) compared to Ibuprofen 400 mg, Morphine 60 mg and Placebo in Patients with acute Pain Following Orthopedic Surgery (Bunionectomy). |
|
A randomized double-blind, Placebo and active comparator controlled parallel group multi-center study of study medication and naprelan in the treatment of post-bunionectomy surgery pain |
|
A Randomized, Double-Blind, Parallel-Group, Dose-Ranging Study Assessing the Analgesic Efficacy and Safety of Five Dose Levels of CG5503 (25 mg, 50 mg, 75mg, 100 mg, and 200 mg) compared to Morphine 60mg, Ibuprofen 400 mg,and Placebo in patients following Orthopedic Surgery (Bunionectomy). |
|
Analgesic Efficacy of Single doses of Investigational Medication (900mg, 1350mg, 1800mg) and Multiple Doses of Investigational Medication (900mg UID or 450 mg BID) Compared with Single and Multiple doses of Naproxen Sodium 500mg or placebo in Patients with Pain from Outpatient Orthopedic surgery (Bunionectomy). |
|
Comparative Analgesic Efficacy of Single and Multiple Doses of Investigational Medication (900mg, 1350mg, 1800mg), Naproxen Sodium 550mg or Placebo in Pain Following Outpatient Orthopedic surgery (Bunionectomy). |
|
Clinical Protocol for A Double blind Placebo and Active-Controlled Comparison of the Analgesic Activity of Investigational Medication 40mg Oxycodone 10mg/acetaminophen 1000mg (Tylox) and Placebo in Post Bunionectomy Surgical Patients |
|
A Multi-Center, Single Dose, Double-blind, Placebo-Controlled, Randomized, Pilot Study To Investigate the Assay Sensitivity of Single Digit Hammertoe Surgery As A Model For The Study Of Analgesic Drugs In Acute Pain. |
|
A Randomized, Multi-Center Double-Blind Study Comparing the Analgesic Efficacy of Extended Release Investigational Medication and Placebo in Subjects with Osteoarthritis of the Hip or Knee |
|
A Randomized, Double-Blind, Placebo-Controlled Trial to Assess Safety and Tolerability during Treatment of Type 2 Diabetes with Usual Diabetes Therapy and either Investigational Medication or Placebo. |
|
A Phase II, Double Blind, Randomized, Placebo Controlled, Dose-Ranging Study of the Efficacy, Safety, and Tolerability of Investigational Medication in Patients with Mild to Moderate Uncomplicated Essential Hypertension. |
|
A Three Stage, Modified-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Investigational Medication Gel Applied 5 Times per Week for 4 Weeks for the Treatment of Common Warts in Adults. |
|
A Phase III, Randomized, Open-Label Study to Assess The Safety and Efficacy of Investigational Medication Injection Versus Midazolam HCL for Sedation in Patients Undergoing Minor Surgical Procedures. |
|
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600 mg/day) in Subjects with Painful Distal Diabetic Neuropathy |
|
Randomized, Double-Blind, Placebo-Controlled Trial of Investigational Medication In Subjects With Painful Intermetatarsal Neuroma |
|
An Open-Label Study Evaluating the Safety and Tolerability of Long Term Administration of Investigational Drug in Subjects with Moderate to Severe Chronic Non-Malignant Pain |
|
A Multi-center, Open-label, Follow-on Trial to Assess the Long-term Safety and Efficacy of Investigational Drug in Subjects with Painful Distal Diabetic Neuropathy |
|
A Multi-Center, Standard of Care-Controlled Study to Evaluate the Long-Term Safety of Investigational Drug for the Treatment of Chronic Low Back Pain |
|
A Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of Investigational Drug at Two Dose Levels in the Treatment of the Pain of Diabetic Neuropathy |
|
A Long-Term, Open-Label, Safety Study of Investigational Drug in Patients with Moderate to Severe Chronic Low Back Pain or with Moderate to Severe Chronic Pain Due to Osteoarthritis of the Hip or Knee |
|
A Multicenter, Randomized, Double-Blind. Placebo-Controlled, Phase III, Efficacy & Safety Study of Investigational Drug in Patients with Moderate to Severe Chronic Pain Due to Osteoarthritis of the Hip or Knee |
|
A Phase 3, Randomized, Multicenter, Double-Blind Study Comparing the Analgesic Efficacy of Extended Release Investigational Drug to Placebo in Subjects with Osteoarthritis |
|
Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study of the Analgesic Efficacy of Investigational Drug in Subjects with Pain Following Bunionectomy Surgery |
|
A Randomized Double-Blind, Placebo- and Active-Control, Parallel-arm, Phase III Trial with Controlled Adjustment of Dose to Evaluate the Efficacy and Safety of Extended-Release (ER) Study Medication in Subjects with Moderate to Severe Chronic Low Back Pain |
|
A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of the Sterile Lidocaine Hydrochloride Monohydrate (LHM) Product in Adult Subjects |
|
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Study Medication for Sedation During Monitored Anesthesia Care |
|
A Phase 3, Randomized, Multicenter, Double-Blind, Allopurinol-Controlled Study Assessing the Efficacy and Safety of Oral Study Medication in Subjects With Gout. |
|
A Randomized-Withdraw Phase III Study Evaluating the Safety and Efficacy of Study Medication Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN) |
|
A Phase 3, 53 Weeks Study on Analgesic Efficacy and Safety of Study Medication: 26-Week, Randomized, Parallel-Group, Double-Blind, Placebo (13 Weeks)- and Naproxen (26 Weeks)-Controlled, Multicenter Study of Study Medication with a 26-Week Naproxen-Controlled Safety Follow-up in Subjects with Osteoarthritis of the Knee, and a 1-Week Post-treatment Safety Follow-up |
|
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter, Repeat-dose Study of the Safety and Efficacy of Study Medication Tablets for the Treatment of Acute, Moderate to Severe Post-operative Pain Following Bunionectomy Surgery in Adult Patients |
|
A Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group study to Evaluate Efficacy and Safety of a Single Intra operative Administration of Study Drug in Patients Undergoing Transpositional First Metatarsal Osteotomy (Bunionectomy) for the Correction of Hallux Valgus Deformity |
|
Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study of the Analgesic Efficacy of Study Medication in Subjects with Pain Following Bunionectomy |
|
A Double-Blind, Randomized, Multi-Center, Repeat-Dose, Comparison of the Analgesic Efficacy and Safety of the Opioid Combination (Study Drug) to each of the Individual Milligram Components (Oxycodone and Morphine) in the Management of Acute Moderate to Severe Pain Following Bunionectomy Surgery |
